U.K. Upholds One Lipitor Patent, Invalidates Another

Law360, New York (October 12, 2005, 12:00 AM EDT) -- In a decision that both pharmaceutical companies Pfizer and Ranbaxy plan to appeal, a U.K. court has upheld one of Pfizer’s patents for billion-dollar drug Lipitor and has ruled another invalid.

The decision comes as many wait for the outcome of a similar case between the two companies currently being tried in the United States.

Pfizer said the company was pleased with the decision, although it plans to appeal the invalidity ruling.

"This court decision is consistent with the fundamental principle that patent laws exist to...
To view the full article, register now.